DRY INHALATION POWDER

FIELD: pharmaceutical industry. SUBSTANCE: novel agent improving moisture resistance and reducing influence of permeating moisture on fine fraction of dry inhalation powder represents magnesium stearate. EFFECT: allowed increase of doses of disperse particles and their fine fraction, essentially inc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MJULLER-VAL'TS RUDI, KELLER MANFRED
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: pharmaceutical industry. SUBSTANCE: novel agent improving moisture resistance and reducing influence of permeating moisture on fine fraction of dry inhalation powder represents magnesium stearate. EFFECT: allowed increase of doses of disperse particles and their fine fraction, essentially increased stability of the latter on storage at 40 C and relative humidity 75%. 21 cl, 6 tbl, 8 ex